Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients.
Helen R GosseltCostanza L VallergaPooja R MandaviyaErik LubbertsJohanna M W HazesRobert de JongeSandra G HeilPublished in: PloS one (2021)
No baseline genome-wide significant differences were identified as biomarker for MTX (combination) therapy response; hence meta-analyses are required.